logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Kangshen Pharmaceutical (01681.HK) spent HK$378,900 on June 24 to repurchase 30,000 shares.

date
24/06/2026
Wise Finance News APP, Healthcon Pharmaceutical (01681.HK) announced that it will spend HKD 378,900 to repurchase 30,000 shares on June 24, 2026.
Latest
3 m ago
Google's parent company Alphabet saw its stock price rise by 1.3%; the company will replace Verizon Communications and be included in the Dow Jones Industrial Average.
4 m ago
Wendy's stock price surged 37% before trading was suspended due to volatility.
4 m ago
France faces record-breaking heatwave, attractions such as the Louvre are closing early.
4 m ago
Gold and Bitcoin plummet, the US dollar stages a strong comeback! "Devaluation trading" rapidly declines as Powell takes charge of the Federal Reserve and becomes the core driving force.
5 m ago
Cloudberry Valley Technology (03310.HK) issued 7.9288 million shares due to the exercise of oversubscribed rights issue.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.